Enrique Gómez de la Fuente, Isam Alobid, Iñigo Ojanguren, Virginia Rodríguez-Vázquez, Beatriz Pais, Víctor Reyes, Miriam Espinosa, África Luca de Tena, Irantzu Muerza, Eduard Vidal-Barraquer
BACKGROUND: Patients with asthma (AS), atopic dermatitis (AD), allergic rhinitis (AR), eosinophilic esophagitis (EoE), chronic rhinosinusitis with nasal polyps (CRSwNP), chronic urticaria (CU), non-steroidal anti-inflammatory drugs-exacerbated respiratory disease (N-ERD), and certain phenotypes of chronic obstructive pulmonary disease (COPD), among others, have a common underlying pathogenesis known as Type 2 inflammation (T2i). These diseases often coexist with other T2i conditions and have a substantial impact on the quality of life (QoL) of patients...
2023: Front Allergy